Objective To study the advances in research of breast cancer during pregnancy. Methods The literatures in recent years were reviewed. Results A lot of evidences suggested that the diagnosis may be delayed easily. The diagnosis was primarily made by needle aspiration cytology and biopsy. The treatment of pregnant breast cancer was not different from ordinary breast cancer, however the factor of foetus should be taken into account. Termination of pregnancy did not improve survival. Conclusion Pregnant breast cancer is mostly at later stage at the time of diagnosis and has poorer prognosis than ordinary breast cancer. The patients with breast cancer during pregnancy usually have an equivalent survival rate when compared with age and stagematched ordinary group. Future pregnancy may be allowed after two years of treatment in patients with early breast cancer.
Objective To investigate the incidence of full-term prelabor rupture of membranes (FPROM) and risk factors for FPROM. Methods A prospective nested case-control study was performed on pregnant women in early pregnancy and their spouses, who underwent prenatal examination for the first time in Zhuhai Center for Maternal and Child Health Care from May 2021 to December 2022. Pregnant women with a clear diagnosis of FPROM were included in the case group, and pregnant women without FPROM were randomly selected at a 1∶3 ratio for inclusion in the control group. A questionnaire survey was performed to collect exposure information possibly related to FPROM. The hospital's medical record system was used for information verification and to record the pregnancy outcomes. A multivariate logistic regression analysis was used to investigate the risk factors for FPROM. Results The incidence of FPROM in this study was 24.27%. The multivariate logistic regression analysis showed that obesity pregnant women, smoking, drinking, unbalanced diet, high-intensity physical activity during pregnancy, eating areca nut before pregnancy, using glucocorticoids during pregnancy, older at the time of first pregnancy, a history of adverse pregnancy outcomes, a history of pregnancy complications, a history of diabetes, a history of scar uterus, no folate supplementation during pregnancy, repeated intrauterine operations, polyembryony, polyhydramnios, transverse fetus and fetal cephalopelvic disproportion as the way of conception were risk factors for FPROM (P<0.05). Additionally, the pregnant women whose spouses were obese or smoked or drinking had an increased risk of FPROM (P<0.05). Lower gravidity and lower parity were protective factors against FPROM (P<0.05). Conclusion There are many risk factors for FPROM. Special attention should be given to the life behaviors of pregnant women during pregnancy, and health education should be strengthened for pregnant women and their spouses to help them develop good living habits and reduce the incidence of FPROM.
High-flow nasal cannula (HFNC) oxygen therapy, which is important in noninvasive respiratory support, is increasingly being used in critically ill neonates with respiratory failure because it is comfortable, easy to set up, and has a low incidence of nasal trauma. The advantages, indications, and risks of HFNC have been the focus of research in recent years, resulting in the development of the application. Based on current evidence, we developed guidelines for HFNC in neonates using the grading of recommendations assessment, development and evaluation (GRADE). The guideline was formulated after extensive consultations with neonatologists, respiratory therapists, nurse specialists, and evidence-based medicine experts. We have proposed 24 recommendations for 9 key questions. This guideline aims to be a source of evidence and references of HFNC oxygen therapy in clinical practice, and so that more neonates and their families will benefit from HFNC.